SEC Filing Summary

Matthew Mazdyasni, a director at Astrana Health, Inc., acquired 4,525 shares of restricted common stock on June 10, 2026. These shares were granted under the company's 2024 Equity Incentive Plan and will vest on the earlier of June 10, 2027, or the date of the company's 2027 annual meeting of stockholders. Following this transaction, Mazdyasni directly owns 39,288 shares. The transaction code "A" indicates an acquisition, and the price per share was $0.00, consistent with a stock grant.